![Isabel Aznarez π³οΈβππΊπ¦π₯₯π΄ Profile](https://pbs.twimg.com/profile_images/1059940038874546176/iN2u4Xbs_x96.jpg)
Isabel Aznarez π³οΈβππΊπ¦π₯₯π΄
@isa_aznarez
Followers
536
Following
6K
Statuses
2K
Co-founder & SVP, Head of Research, Stoke Therapeutics. Rare diseases, ASOs, photography. Tweets reflect my views only & donβt reflect the companyβs stance.
Boston, MA
Joined May 2016
RT @StokeTx: Today, our investigational new medicine for #DravetSyndrome received @US_FDA Breakthrough Therapy designation. With no approvβ¦
0
5
0
RT @StokeTx: Today on Autosomal Dominant Optic Atrophy (ADOA) Awareness Day, Stoke is standing alongside individuals and families affectedβ¦
0
2
0
RT @StokeTx: Living with #DravetSyndrome takes resilience. Not only from patients but also from the caregivers who support them every day.β¦
0
3
0
RT @StokeTx: Today on #SUDEPActionDay2024, weβre raising awareness about Sudden Unexpected Death in Epilepsy (#SUDEP) and the importance ofβ¦
0
2
0
RT @StokeTx: Today, Stoke announced highlights from presentations at theΒ 15thΒ European Epilepsy CongressΒ related to the Companyβs work to dβ¦
0
1
0
RT @StokeTx: Stoke is pleased to announce the appointment of Eric Olson as Chief Business Officer. Mr. Olson brings two decades of successβ¦
0
1
0
RT @StokeTx: TOMORROW: Stoke CEO Dr. Edward Kaye will discuss leadership strategies for #biotech executives at @BosBizJournal's Biotech inβ¦
0
1
0
RT @StokeTx: This yearβs DSF Biennial Conference allowed our team to connect with patient families, advocates, and other life science compaβ¦
0
1
0
RT @OTSociety: Time Is Running Short! SUBMISSIONS ARE DUE NEXT WEEK! It may take time to get letters of support for some submissions, so pβ¦
0
3
0